New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
10:00 EDTAYI, FCX, SPLK, WSH, SNBC, OPEN, NFX, MON, INTC, LLY, EEPOn The Fly: Analyst Upgrade Summary
Acuity Brands (AYI) upgraded to Buy from Hold at Canaccord... Eli Lilly (LLY) upgraded to Outperform from Market Perform at Cowen... Intel (INTC) upgraded to Overweight from Neutral at Piper Jaffray... Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan... Newfield Exploration (NFX) upgraded to Buy from Neutral at UBS... OpenTable (OPEN) upgraded to Buy from Neutral at Citigroup... Sun Bancorp (SNBC) upgraded to Neutral from Underperform at Sterne Agee... Willis Group (WSH) upgraded to Buy from Neutral at Nomura... Splunk (SPLK) upgraded to Outperform from Underperform at CLSA... Freeport McMoRan (FCX) upgraded to Outperform from Neutral at Macquarie... Enbridge Energy (EEP) upgraded at Credit Suisse.
News For AYI;LLY;INTC;MON;NFX;OPEN;SNBC;WSH;SPLK;FCX;EEP From The Last 14 Days
Check below for free stories on AYI;LLY;INTC;MON;NFX;OPEN;SNBC;WSH;SPLK;FCX;EEP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 24, 2014
21:56 EDTINTCB. Riley to hold a tour
Silicon Valley Tech Tour travels throughout Silicon Valley on August 25-27.
August 22, 2014
08:15 EDTMONMonsanto can execute another reinvention, says Citigroup
Citigroup believes Monsanto is reinventing itself like it did when Roundup went off patent in the late 1990's by using the cash flow from the seeds business to get into new growth areas. Citi thinks management can execute the transition but admits the stock may be range-bound over the near-term. The firm keeps a Buy rating on Monsanto with a $146 price target.
August 21, 2014
09:45 EDTNFXNewfield Exploration management to meet with UBS
Subscribe for More Information
07:12 EDTLLYEli Lilly announces results from pivotal UNCOVER studies for ixekizumab
Eli Lilly announces that its investigational medicine ixekizumab was statistically superior to etanercept and placebo on all skin clearance measures in Phase 3 studies. Patients treated with both dosing regimens of ixekizumab had significantly greater levels of skin clearance compared to placebo and to etanercept at the 12-week endpoint. Skin clearance was measured by standard primary endpoints for psoriasis studies: the Psoriasis Area and Severity Index and the Static Physician Global Assessment. For patients treated with ixekizumab either every four weeks or every two weeks, between 78 to 90 percent of patients achieved at least a 75 percent reduction in PASI score at 12 weeks. Additionally, 31 to 41 percent of these patients achieved PASI 100, or clear skin, at week 12. For comparison, between 5 to 7 percent of patients treated with etanercept in the UNCOVER-2 and 3 studies achieved PASI 100. Adverse events were comparable for patients receiving ixekizumab in the 12-week, randomized control portion across all three studies.
06:23 EDTSPLKSplunk price target lowered to $55 from $65 at Deutsche Bank
Deutsche Bank lowered its price target for Splunk (SPLK) shares to $55 from $65 ahead of the company's Q2 results on August 28 and says it prefers Tableau (DATA) on a relative basis. Deutsche, however, keeps a Buy rating on Splunk, noting that its recent user checks didn't pick up anything incrementally negative. The firm believes the Street is cautious on the stock into the results.
August 20, 2014
13:05 EDTINTCIntel and Unity collaborate to extend Android support across Intel-based devices
Subscribe for More Information
12:07 EDTMONMonsanto expects to at least double year ongoing EPS by end of FY19
Subscribe for More Information
12:03 EDTMONMonsanto says on track to deliver upper end of FY14 outlook
Subscribe for More Information
August 18, 2014
17:37 EDTLLYFDA grants tentative approval for Lilly, Boehringer Basaglar insulin
Subscribe for More Information
11:41 EDTLLYCubist rises after report sparks takeover interest speculation
Subscribe for More Information
10:29 EDTINTCGoldman cuts sector view on semiconductors to Cautious
Subscribe for More Information
08:04 EDTINTCSemiconductors sector downgraded to Cautious from Neutral at Goldman
Goldman downgraded the Semiconductors sector to Cautious given signs the cycle is turning based on expectations for a slowdown in semiconductor revenue growth, above trend semi unit shipments that should normalize, and stretching lead times. As a result, the analyst sees risk to Q4 estimates and sees further downside of 10%-25% for the SOX (SOX) and downgraded NXP Semiconductors (NXPI) to Sell from Neutral, InvenSense (INVN) to Neutral from Buy, and removed Maxim Integrated (MXIM) from the Conviction Buy List.
August 15, 2014
06:23 EDTINTCIntel teaming with SMS Audio for biometric earbuds, WSJ reports
Subscribe for More Information
August 14, 2014
17:16 EDTFCXPaulson & Co gives quarterly update on stakes
Subscribe for More Information
10:05 EDTFCXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Adidas (ADDYY) downgraded to Neutral from Buy at Goldman... Fabrinet (FN) downgraded at B. Riley... Freeport McMoRan (FCX) downgraded at Stifel... Infosys (INFY) downgraded to Hold from Buy at Jefferies... InterMune (ITMN) downgraded to Neutral from Buy at Goldman... Jones Energy (JONE) downgraded to Neutral from Overweight at JPMorgan... LVMH Moet Hennessy (LVMUY) downgraded to Neutral from Buy at Goldman... Madison Square Garden (MSG) downgraded to Hold from Buy at Topeka... Qualys (QLYS) downgraded to Sector Perform from Outperform at RBC Capital... SeaWorld (SEAS) downgraded to Market Perform from Outperform at Wells Fargo... Theravance Biopharma (TBPH) downgraded to Underperform from Neutral at RW Baird... URS Corporation (URS) downgraded to Neutral from Buy at Sterne Agee... ViaSat (VSAT) downgraded to Perform from Outperform at Oppenheimer... Wynn Resorts (WYNN) downgraded to Hold from Buy at Gabelli.
07:52 EDTFCXFreeport McMoRan downgraded at Stifel
As previously reported, Stifel downgraded Freeport McMoRan to Hold from Buy. The firm downgraded shares due to valuation.
06:18 EDTFCXFreeport McMoRan downgraded to Hold from Buy at Stifel
August 13, 2014
17:38 EDTINTCAvago to sell Axxia Networking Business to Intel for $650M
Subscribe for More Information
17:05 EDTNFXNewfield Exploration files automatic mixed securities shelf
Subscribe for More Information
05:59 EDTINTCIntel could invest up to $100B in Oregon over 30 year period
Washington County, a political subdivision of the State of Oregon, the City of Hillsboro, a municipal corporation, and Intel have entered into a strategic investment program agreement. The SIP application requested that Intel and the County enter into a SIP Agreement to provide a framework for potential additional Intel investment in Oregon of up to $100B over a 30 year period commencing around the time when the current SIP agreement between Intel and the County approaches or reaches the limits of its current investment ceiling. In general terms, Intelís investment will consist primarily of proposed investments in semiconductor manufacturing equipment and facilities to promote job retention of its semiconductor manufacturing and semiconductor technology development work force. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use